Wickham Labs to exhibit at Making Pharmaceuticals 2016

Published: 14-Mar-2016
Manufacturing

Company will be leading a discussion at the conference on Wednesday 27 April on the 'Development and Implementation of In Vitro Methods'


Wickham Laboratories Ltd will exhibit on Stand 307 at Making Pharmaceuticals, to be held in Birmingham, UK from 26-27 April 2016.

Making Pharmaceuticals is a key event for the UK pharmaceutical industry, offering attendees access to more than 100 exhibitors and more than 70 seminars and workshops. This is the only dedicated free-to-attend conference within the UK focused on sourcing, manufacturing and outsourcing for pharmaceutical product development.

We are pleased to be a part of the specialised conference programme and will be leading a discussion at the conference on Wednesday 27 April at 9:55am BST on the 'Development and Implementation of In Vitro Methods'. Further details and information on our seminar can be found on the Making Pharmaceuticals conference website.

We look forward to seeing our clients and colleagues again this April in Birmingham - please come and see us on Stand 307 to discuss your service requirements.

  • Companies:
  • Wickham Micro
See more

You may also like

Manufacturing

Wickham Labs to exhibit at Medtec Ireland 2017

Read more
Wickham Laboratories announced it will be on stand 305 at the upcoming Medtec Ireland, held on 4-5 October 2017 at the Radisson Blu Hotel in Galway, Ireland

Trending Articles

  1. Sanofi invests €40m into biopharmaceutical manufacturing at its Lyon Gerland site The pharma giant has expanded its French monoclonal antibody production capabilities, while also dedicating €25m to the development of a second-gen polyclonal antibody
  2. IMed supports K2 medical systems in their EU MDR transition Consultancy firm helps K2 navigate the complex regulatory process to achieve Article 97 compliance
  3. IMed Consultancy helps Toby Orthopaedics navigate UK regulations Regulatory consultancy ensures compliance and confidence for Miami-based company
  4. Ardena's Oss nanomedicine facility gains full GMP approval from the Dutch Healthcare Authority The pharmaceutical manufacturing facility can produce advanced nanoparticle drug delivery systems, including lipid-based, polymeric and metal oxide nanoparticles
  5. Pharmaceutics International bolsters its prefilled syringe production capabilities The aseptic and oral dosage CDMO has invested USD $3.6m into advanced labelling, fill/finish and automated visual inspection technologies at its Hunt Valley site in Maryland, US

Upcoming event

CPhI India

26–28 November 2024 | Online Conference & Networking | Delhi, India See all

You may also like

Manufacturing

Wickham Labs to exhibit at Medtec Ireland 2017

Wickham Laboratories announced it will be on stand 305 at the upcoming Medtec Ireland, held on 4-5 October 2017 at the Radisson Blu Hotel in Galway, Ireland
Containment

Wickham Laboratories expands sterility testing capabilities

Wickham Laboratories announces completion of validation on a fourth isolator
Manufacturing

Wickham Labs to exhibit at Med-Tech

Wickham Laboratories will be Stand 12 at the upcoming Med-Tech Innovation Expo, Ricoh Arena, Coventry, April 26–27.
Manufacturing

Samsung Biologics bags $668 manufacturing deal with European pharmaceutical company

The CDMO will be responsible for the manufacture of the client's biopharmaceuticals until December 2031
Manufacturing

CDMO GBI Biomanufacturing expands US drug product services with aseptic fill/finish capabilities

Its Florida site will now be able to support biopharma clients from clinical trials to commercialisation with a dual manual/automated fill/finish approach
Manufacturing

Sartorius Stedim Biotech supports bioprocess development with new Innovation Centre

The Massachusetts, US-based Centre for Bioprocess Innovation is a collaborative space designed to develop and optimise biomanufacturing processes
Manufacturing

Abzena adds cell-based potency testing to its UK and US analytical service offering

The CDMO and CRO will now be able to develop GMP cell-based potency assays, which are crucial in measuring biopharmaceutical activity
Subscribe now